Zobrazeno 1 - 10
of 2 104
pro vyhledávání: '"Cobbold M"'
Autor:
Barrett AM; AstraZeneca (United States), Gaithersburg, MD, United States., Britton ZT; AstraZeneca (United States), Gaithersburg, MD, United States., Carrasco RA; AstraZeneca (United States), Gaithersburg, MD, United States., Breen S; AstraZeneca (United States), Gaithersburg, MD, United States., Broggi MAS; AstraZeneca (United States), Gaithersburg, MD, United States., Hatke A; AstraZeneca (United States), Gaithersburg, MD, United States., Clark B; AstraZeneca (United States), Gaithersburg, MD, United States., Yang C; AstraZeneca (United States), Gaithersburg, Maryland, United States., Phipps S; AstraZeneca (United States), Gaithersburg, MD, United States., Ortiz L; AstraZeneca (United States), Gaithersburg, MD, United States., Janocha B; AstraZeneca (United States), Gaithersburg, MD, United States., Zanvit P; AstraZeneca (United States), Gaithersburg, MD, United States., Giraldo NA; AstraZeneca (United States), Gaithersburg, MD, United States., Martin PL; AstraZeneca (United States), Gaithersburg, Maryland, United States., Lapointe JM; AstraZeneca (United Kingdom), Cambridge, United Kingdom., Harder N; AstraZeneca (United States), Munich, Germany., Cornish GH; AstraZeneca (United Kingdom), Cambridge, United Kingdom., Attili BNNR; AstraZeneca (United Kingdom), Cambridge, United Kingdom., Mazor Y; AstraZeneca (United States), Gaithersburg, United States., Damschroder M; AstraZeneca (United States), Gaithersburg, MD, United States., Cobbold M; AstraZeneca (United States), Gaithersburg, MD, United States., Moody G; AstraZeneca (United States), Gaithersburg, MD, United States., Bosco EE; AstraZeneca (United States), Gaithersburg, MD, United States.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Sep 25. Date of Electronic Publication: 2024 Sep 25.
Autor:
Zhang S, Yan C, Millar DG, Yang Q, Heather JM, Langenbucher A, Morton LT, Sepulveda S, Alpert E, Whelton LR, Zarrella DT, Guo M, Minogue E, Lawrence MS, Rueda BR, Spriggs DR, Lu W, Langenau DM, Cobbold M
Publikováno v:
Cancer research [Cancer Res] 2024 May 02; Vol. 84 (9), pp. 1534.
Autor:
Hardaker EL; Oncology R&D, AstraZeneca, Cambridge, UK., Sanseviero E; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Karmokar A; Oncology R&D, AstraZeneca, Cambridge, UK., Taylor D; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Milo M; Oncology R&D, AstraZeneca, Cambridge, UK., Michaloglou C; Oncology R&D, AstraZeneca, Cambridge, UK., Hughes A; Oncology R&D, AstraZeneca, Cambridge, UK., Mai M; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., King M; Oncology R&D, AstraZeneca, Cambridge, UK., Solanki A; Oncology R&D, AstraZeneca, Cambridge, UK., Magiera L; Oncology R&D, AstraZeneca, Cambridge, UK., Miragaia R; Oncology R&D, AstraZeneca, Cambridge, UK., Kar G; Oncology R&D, AstraZeneca, Cambridge, UK., Standifer N; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA.; Tempest Therapeutics, Brisbane, CA, USA., Surace M; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Gill S; Oncology R&D, AstraZeneca, Cambridge, UK., Peter A; Oncology R&D, AstraZeneca, Cambridge, UK., Talbot S; Oncology R&D, AstraZeneca, Cambridge, UK., Tohumeken S; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Fryer H; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Mostafa A; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Mulgrew K; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Lam C; Oncology R&D, AstraZeneca, Cambridge, UK., Hoffmann S; Imaging and Data Analytics, AstraZeneca, Cambridge, UK., Sutton D; Imaging and Data Analytics, AstraZeneca, Cambridge, UK., Carnevalli L; Oncology R&D, AstraZeneca, Cambridge, UK., Calero-Nieto FJ; Oncology R&D, AstraZeneca, Cambridge, UK., Jones GN; Oncology R&D, AstraZeneca, Cambridge, UK., Pierce AJ; Oncology R&D, AstraZeneca, Cambridge, UK.; Crescendo Biologics Limited, Cambridge, UK., Wilson Z; Oncology R&D, AstraZeneca, Cambridge, UK., Campbell D; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Nyoni L; Oncology R&D, AstraZeneca, Cambridge, UK., Martins CP; Oncology R&D, AstraZeneca, Cambridge, UK., Baker T; CPSS AST, AstraZeneca, Cambridge, UK., Serrano de Almeida G; CPSS AST, AstraZeneca, Cambridge, UK., Ramlaoui Z; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Bidar A; CPSS, Imaging, AstraZeneca, Gothenburg, Sweden., Phillips B; Data Sciences & Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Boland J; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Iyer S; Oncology R&D, AstraZeneca, Boston, MA, USA., Barrett JC; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Loembé AB; Early Clinical Development, AstraZeneca, Oss, the Netherlands., Fuchs SY; Department of Biomedical Sciences, School of Veterinary Medicine University of Pennsylvania, Philadelphia, PA, 19104, USA., Duvvuri U; UPMC Department of Otolaryngology and UPMC Hillman Cancer Center, 200 Lothrop St. Suite 500, Pittsburg, PA, 15213, USA., Lou PJ; National Taiwan University Hospital, No. 7, Chung Shan S. Rd. (Zhongshan S. Rd.), Zhongzheng Dist., Taipei City, 10002, Taiwan., Nance MA; VA Pittsburgh Healthcare System, University Drive C, Pittsburg, PA, 15240, USA., Gomez Roca CA; Institut Claudius Regaud-Cancer Comprehensive Center, 1 Avenue Irene Joliot-Curie, IUCT-O, Toulouse, 31059 Cedex 9, France., Cadogan E; Oncology R&D, AstraZeneca, Cambridge, UK., Critichlow SE; Oncology R&D, AstraZeneca, Cambridge, UK., Fawell S; Oncology R&D, AstraZeneca, Boston, MA, USA., Cobbold M; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA., Dean E; Oncology R&D, AstraZeneca, Cambridge, UK., Valge-Archer V; Oncology R&D, AstraZeneca, Cambridge, UK., Lau A; Oncology R&D, AstraZeneca, Cambridge, UK., Gabrilovich DI; Oncology R&D, AstraZeneca, Gaithersburg, MD, 20878, USA. dmitry.gabrilovich@astrazeneca.com., Barry ST; Oncology R&D, AstraZeneca, Cambridge, UK. simon.t.barry@astrazeneca.com.
Publikováno v:
Nature communications [Nat Commun] 2024 Feb 24; Vol. 15 (1), pp. 1700. Date of Electronic Publication: 2024 Feb 24.
Autor:
Zanvit P; Early Oncology Research., van Dyk D; Biologics Engineering., Fazenbaker C; Early Oncology Research., McGlinchey K; Early Oncology Research., Luo W; Early Oncology Research., Pezold JM; Early Oncology Research., Meekin J; Early Oncology Research., Chang CY; Biologics Engineering., Carrasco RA; Early Oncology Research., Breen S; Early Oncology Research., Cheung CS; Biologics Engineering., Endlich-Frazier A; Biologics Engineering., Clark B; Biologics Engineering., Chu NJ; Early Oncology Research., Vantellini A; Discovery Sciences, Oncology R&D, and., Martin PL; Oncology Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA., Hoover CE; Clinical Pathology Patient Safety, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Riley K; Clinical Pathology Patient Safety, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Sweet SM; Oncology Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA., Chain D; Oncology Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA., Kim YJ; Oncology Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA., Tu E; Oncology Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA., Harder N; Computational Pathology, AstraZeneca, Munich, Germany., Phipps S; Biologics Engineering., Damschroder M; Biologics Engineering., Gilbreth RN; Biologics Engineering., Cobbold M; Early Oncology Research., Moody G; Early Oncology Research., Bosco EE; Early Oncology Research.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2023 Nov 15; Vol. 133 (22). Date of Electronic Publication: 2023 Nov 15.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Transfusion Medicine. Dec2003, Vol. 13 Issue 6, p405-415. 11p.
Autor:
Heather JM; Massachusetts General Hospital Cancer Center, Charlestown, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Spindler MJ; GigaMune, Inc., South San Francisco, CA, USA., Alonso MH; Massachusetts General Hospital Cancer Center, Charlestown, MA, USA., Shui YI; Massachusetts General Hospital Cancer Center, Charlestown, MA, USA., Millar DG; Massachusetts General Hospital Cancer Center, Charlestown, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Johnson DS; GigaMune, Inc., South San Francisco, CA, USA., Cobbold M; Massachusetts General Hospital Cancer Center, Charlestown, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Hata AN; Massachusetts General Hospital Cancer Center, Charlestown, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.
Publikováno v:
Nucleic acids research [Nucleic Acids Res] 2022 Jul 08; Vol. 50 (12), pp. e68.
Autor:
Zhang S; Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases & Department of Gynecologic Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Yan C; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Molecular Pathology Unit, Massachusetts General Hospital Research Institute, Charlestown, Massachusetts., Millar DG; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Yang Q; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Molecular Pathology Unit, Massachusetts General Hospital Research Institute, Charlestown, Massachusetts., Heather JM; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Langenbucher A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Morton LT; University of Birmingham, Birmingham, United Kingdom., Sepulveda S; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Alpert E; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Molecular Pathology Unit, Massachusetts General Hospital Research Institute, Charlestown, Massachusetts., Whelton LR; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Molecular Pathology Unit, Massachusetts General Hospital Research Institute, Charlestown, Massachusetts., Zarrella DT; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts.; Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, Massachusetts., Guo M; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Minogue E; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Lawrence MS; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Rueda BR; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts.; Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, Massachusetts., Spriggs DR; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Lu W; Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases & Department of Gynecologic Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China., Langenau DM; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; Molecular Pathology Unit, Massachusetts General Hospital Research Institute, Charlestown, Massachusetts., Cobbold M; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts.; AstraZeneca, Gaithersburg, Maryland.
Publikováno v:
Cancer research [Cancer Res] 2022 Mar 01; Vol. 82 (5), pp. 773-784.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hashimoto A; Wistar Institute, Philadelphia, Pennsylvania.; AstraZeneca, Gaithersburg, Maryland., Sarker D; Kings College London, London, UK., Reebye V; Imperial College London, London, UK. v.reebye@ic.ac.uk dmitry.gabrilovich@astrazeneca.com nagy@minatx.com.; MiNA Therapeutics Ltd, London, UK., Jarvis S; Imperial College London, London, UK., Sodergren MH; Imperial College London, London, UK., Kossenkov A; Wistar Institute, Philadelphia, Pennsylvania., Sanseviero E; Wistar Institute, Philadelphia, Pennsylvania., Raulf N; MiNA Therapeutics Ltd, London, UK., Vasara J; MiNA Therapeutics Ltd, London, UK., Andrikakou P; Imperial College London, London, UK., Meyer T; University College London Cancer Institute, London, UK., Huang KW; National Taiwan University, Taipei, Taiwan., Plummer R; Northern Centre for Cancer Care and Newcastle University, Newcastle upon Tyne, UK., Chee CE; National University Cancer Institute Singapore, Singapore., Spalding D; Imperial College London, London, UK., Pai M; Imperial College London, London, UK., Khan S; Imperial College London, London, UK., Pinato DJ; Imperial College London, London, UK., Sharma R; Imperial College London, London, UK., Basu B; University of Cambridge, Cambridge, UK., Palmer D; Department of Molecular and Clinical Cancer Medicine, University of Liverpool and Clatterbridge Cancer Centre, Liverpool, UK., Ma YT; University of Birmingham and University Hospitals Birmingham NHS Trust, Birmingham, UK., Evans J; University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK., Habib R; MiNA Therapeutics Ltd, London, UK., Martirosyan A; HalioDx, Marseille, France., Elasri N; HalioDx, Marseille, France., Reynaud A; HalioDx, Marseille, France., Rossi JJ; Department of Molecular and Cellular Biology, Beckman Research Institute of City of Hope, Duarte, California., Cobbold M; AstraZeneca, Gaithersburg, Maryland., Habib NA; Imperial College London, London, UK. v.reebye@ic.ac.uk dmitry.gabrilovich@astrazeneca.com nagy@minatx.com.; MiNA Therapeutics Ltd, London, UK., Gabrilovich DI; AstraZeneca, Gaithersburg, Maryland. v.reebye@ic.ac.uk dmitry.gabrilovich@astrazeneca.com nagy@minatx.com.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Nov 01; Vol. 27 (21), pp. 5961-5978. Date of Electronic Publication: 2021 Aug 18.